Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer
Open Access
- 23 January 2021
- journal article
- Published by Elsevier BV in Medicine in Drug Discovery
- Vol. 10, 100082
- https://doi.org/10.1016/j.medidd.2021.100082
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cellsOncotarget, 2015
- Current trends in using polymer coated gold nanoparticles for cancer therapyInternational Journal of Pharmaceutics, 2015
- Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: Synthesis and biological evaluationEuropean Journal of Pharmaceutical Sciences, 2015
- Anticancer potential of medicinal plants and their phytochemicals: a reviewRevista Brasileira de Botânica, 2015
- Ameliorative Effect of Fisetin on Cisplatin-Induced Nephrotoxicity in Rats via Modulation of NF-κB Activation and Antioxidant DefencePLOS ONE, 2014
- Reactive Oxygen Species, AMP-activated Protein Kinase, and the Transcription Cofactor p300 Regulate α-Tubulin Acetyltransferase-1 (αTAT-1/MEC-17)-dependent Microtubule Hyperacetylation during Cell StressOnline Journal of Public Health Informatics, 2014
- HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Interactions of Engineered Nanoparticles with Organs Protected by Internal Biological BarriersSmall, 2012
- Gold nanoparticles in cancer therapyActa Pharmacologica Sinica, 2011
- Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-κB-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated IκBα Kinase ActivationMolecular Pharmacology, 2007